Enter your login e-mail to the account
Search
Search parameters
Search results
- Treatment of patients with low-risk myelodysplastic syndrome
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2014, Spectrum ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Myelodysplastic syndrome – medicine made to measure
MUDr. Eva Mikušková, doc. MUDr. Ján Staško, PhD., MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(6/2014, Spectrum ) - Treatment options in multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(1/2007, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
doc. MUDr. Martin Mistrík, PhD., doc. MUDr. Angelika Bátorová, PhD., MUDr. Ľubica Roziaková, PhD.
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Marginal zone lymphoma
MUDr. Juraj Ďuraš , MUDr. Michal Kaščák, prof. MUDr. Roman Hájek, CSc.
(5/2017, Spectrum ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Diagnostic and prognostic factors in multiple myeloma
MUDr. Zdenka Štefániková
(3/2016, Spectrum ) - Ixazomib, lenalidomide, dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. František Nehaj, MUDr. Lenka Lisá, PhD., MUDr. Matej Hrnčár, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2020, Review articles ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Lenalidomide in the treatment of mantle cell lymphoma
Doc. MUDr. Ľuboš Drgoňa, CSc., MHA
(6/2017, Drugs & drug classes ) - Prognostic indicators and significance of response in multiple myeloma
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková, MUDr. Lucia Copáková
(2/2013, Focus ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Successful treatment of pomalidomide in ordinary relaps multiple myeloma
MUDr. Miroslav Šimek, PhD.
(S3/2018, Original works & case studies ) - Pomalidomide in heavily pretreated patient with multiple myeloma: a case report
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2018, Original works & case studies ) - Benefits of modern agents in the treatment of multiple myeloma – our experiences
MUDr. Erika Švorcová, MUDr. Juliana Gabzdilová, PhD., MUDr. Kinga Dedinská
(S2/2024, Original works & case studies ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - Smoldering multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(2/2016, Spectrum ) - Peripheral neuropathy in patients with multiple myeloma
MUDr. Juliana Gabzdilová, PhD., MUDr. Diana Horváthová, MUDr. Peter Zimmerman, MUDr. Kinga Dedinská, MUDr. Štefan Raffáč, PhD., MPH, prof. MUDr. PhDr. Peter Kalanin, PhD.
(1/2018, Review articles )
- Thrombosis and lymphoproliferative disorders
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Review articles )